Reply to cinar et al. Comment on "Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874"

被引:0
|
作者
Caruntu, Ana [1 ,2 ]
Caruntu, Constantin [3 ,4 ]
Scheau, Cristian [3 ]
机构
[1] Carol Davila Cent Mil Emergency Hosp, Dept Oral & Maxillofacial Surg, Bucharest 010825, Romania
[2] Titu Maiorescu Univ, Fac Dent Med, Dept Oral & Maxillofacial Surg, Bucharest 031593, Romania
[3] Carol Davila Univ Med & Pharm, Dept Physiol, Bucharest 050474, Romania
[4] NC Paulescu Natl Inst Diabet Nutr & Metab Dis, Dept Dermatol, Bucharest 011233, Romania
来源
MEDICINA-LITHUANIA | 2022年 / 58卷 / 11期
关键词
D O I
10.3390/medicina58111576
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Comment on Althobaiti et al. Potential Association between the Use of Anabolic Steroids and COVID-19 Infection. Healthcare 2022, 10, 196
    Mucino-Bermejo, Maria-Jimena
    HEALTHCARE, 2022, 10 (07)
  • [32] Reply to A. Ruggiero et al. to our article 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity'
    Molinier, Rafaele
    Roger, Anissa
    Genet, Bastien
    Saiag, Philippe
    Funck-Brentano, Elisa
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (01) : E20 - E21
  • [33] Letter to the editor: Comment on Bouziotis et al.'s (2022) Association of body mass index with COVID-19 related in-hospital death
    da Silva, Ana Beatriz Januario
    Barros, Waleska Maria Almeida
    Silva, Beatriz Machado
    Nogueira Souza, Viviane de Oliveira
    Lagranha, Claudia Jacques
    CLINICAL NUTRITION, 2022, 41 (12) : 3127 - 3128
  • [34] Reply to Giansanti et al. The Accessibility and the Digital Divide in the Apps during the COVID-19. Comment on "Cao et al. The Impact of Using mHealth Apps on Improving Public Health Satisfaction during the COVID-19 Pandemic: A Digital Content Value Chain Perspective. Healthcare 2022, 10, 479"
    Cao, Junwei
    Zhang, Guihua
    Liu, Dong
    HEALTHCARE, 2022, 10 (07)
  • [35] Comment on Liu et al. Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life 2022, 12, 1419
    Crimi, Claudia
    Cortegiani, Andrea
    LIFE-BASEL, 2022, 12 (10):
  • [36] Reply to comment on Peto et al. (2020): Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic
    Peto, Julian
    ROYAL SOCIETY OPEN SCIENCE, 2021, 8 (06):
  • [37] Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434
    Volkman, Hannah R.
    Nguyen, Jennifer L.
    Mustapha, Mustapha M.
    Jodar, Luis
    Mclaughlin, John M.
    VACCINES, 2024, 12 (10)
  • [38] Letter to the Editor Regarding: "Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination" by Holland et al., Heart Lung Circ. 2022;31(7):924-33
    Lampejo, Temi
    Durkin, Simon M.
    HEART LUNG AND CIRCULATION, 2022, 31 (10): : E129 - E130
  • [39] Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al.
    Martora, Fabrizio
    Villani, Alessia
    Marasca, Claudio
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (01) : E103 - E105
  • [40] Reply to "A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination" by Manaa et al.
    Camela, Elisa
    Scalvenzi, Massimiliano
    Megna, Matteo
    Potestio, Luca
    Guerrasio, Gianluca
    Fornaro, Luigi
    Fabbrocini, Gabriella
    Costa, Claudia
    DERMATOLOGIC THERAPY, 2022, 35 (12)